Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metabotropic glutamate receptor type 1 (mGluR1/GRM1) is a class C GPCR primarily involved in modulating synaptic transmission via indirect signaling cascades following activation by L-glutamate. It plays essential roles throughout normal brain function but also contributes to disease states when dysregulated—including neurological disorders as well as certain cancers where it may drive tumor growth through effects on cell proliferation or angiogenesis. Its unique structure includes a large extracellular ligand-binding domain forming dimers necessary for function—a feature that underpins its complex regulation within neural circuits as well as emerging therapeutic interest beyond neurology into oncology research domains.
Activates phospholipase C → IP3/DAG pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metabotropic Glutamate Receptor Type 1 (mGluR1).